Emma Hall

25.6k total citations · 3 hit papers
239 papers, 7.8k citations indexed

About

Emma Hall is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Emma Hall has authored 239 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Pulmonary and Respiratory Medicine, 78 papers in Surgery and 56 papers in Oncology. Recurrent topics in Emma Hall's work include Prostate Cancer Treatment and Research (60 papers), Prostate Cancer Diagnosis and Treatment (58 papers) and Advanced Radiotherapy Techniques (50 papers). Emma Hall is often cited by papers focused on Prostate Cancer Treatment and Research (60 papers), Prostate Cancer Diagnosis and Treatment (58 papers) and Advanced Radiotherapy Techniques (50 papers). Emma Hall collaborates with scholars based in United Kingdom, United States and Canada. Emma Hall's co-authors include Robert Huddart, Keith Wheatley, Richard Peto, Richard Doll, Richard Gray, Rebecca Lewis, Christopher M. Nutting, Kevin J. Harrington, Christopher Scrase and Judith M. Bliss and has published in prestigious journals such as New England Journal of Medicine, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Emma Hall

227 papers receiving 7.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

2011 1.2k citations Christopher M. Nutting, James P. Morden et al. The Lancet Oncology profile →
Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors

1994 928 citations Emma Hall et al. profile →
Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer

2012 617 citations Nicholas D. James, Emma Hall et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Emma Hall	2.7k	2.7k	1.7k	1.3k	1.3k	239	7.8k
Srinivasan Vijayakumar	2.9k 1.1×	1.2k 0.4×	1.3k 0.8×	765 0.6×	1.5k 1.1×	269	5.7k
Patti A. Groome	4.2k 1.6×	1.8k 0.7×	3.4k 2.0×	1.2k 0.9×	498 0.4×	168	8.8k
Sarah Burdett	5.3k 2.0×	1.9k 0.7×	3.6k 2.1×	344 0.3×	535 0.4×	56	9.8k
Nicholas G. Zaorsky	3.1k 1.2×	876 0.3×	2.5k 1.4×	157 0.1×	918 0.7×	229	6.7k
Kumar Prabhash	2.6k 1.0×	1.2k 0.4×	2.5k 1.4×	1.3k 1.0×	208 0.2×	531	5.5k
Nicolas Magné	2.1k 0.8×	1.2k 0.5×	2.2k 1.3×	300 0.2×	575 0.4×	318	6.1k
Lisa W. Le	1.8k 0.7×	878 0.3×	2.2k 1.3×	267 0.2×	254 0.2×	184	5.6k
Jeffrey D. Forman	6.0k 2.2×	1.2k 0.4×	1.1k 0.6×	42 0.0×	2.2k 1.7×	140	8.2k
Lawrence Paszat	3.6k 1.3×	2.1k 0.8×	5.7k 3.3×	130 0.1×	484 0.4×	241	8.8k
M.L.G. Janssen‐Heijnen	2.0k 0.8×	1.3k 0.5×	4.0k 2.3×	232 0.2×	119 0.1×	128	6.9k

Countries citing papers authored by Emma Hall

Since Specialization

Citations

This map shows the geographic impact of Emma Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Hall more than expected).

Fields of papers citing papers by Emma Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Hall. The network helps show where Emma Hall may publish in the future.

Co-authorship network of co-authors of Emma Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Hall. A scholar is included among the top collaborators of Emma Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Hall. Emma Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spritzer, Mark D., et al.. (2025). Effects of Testosterone and Its Major Metabolites upon Different Stages of Neuron Survival in the Dentate Gyrus of Male Rats. Biomolecules. 15(4). 542–542.

Price, James, MJ Tyler, James C. Lester, et al.. (2025). Primary results for the phase III trial of Toxicity Reduction using Proton Beam Therapy for Oropharyngeal Cancer (TORPEdO; CRUK/18/010). International Journal of Radiation Oncology*Biology*Physics. 123(4). 1195–1196.

Fog, Lotte S., Emma Hall, Peter S.N. van Rossum, et al.. (2024). ESTRO guidelines for developing questionnaires in survey-based radiation oncology research. Clinical and Translational Radiation Oncology. 51. 100895–100895. 2 indexed citations

Price, James, Sarah Brown, Emma Hall, et al.. (2024). “Why am I still suffering?”: Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapy. Technical Innovations & Patient Support in Radiation Oncology. 30. 100241–100241. 1 indexed citations

Brand, Douglas, Sarah C. Brüningk, Anna Wilkins, et al.. (2023). Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram Definition. International Journal of Radiation Oncology*Biology*Physics. 117(5). 1163–1173. 1 indexed citations

Dearnaley, David P., Clare Griffin, Pedro Leme Silva, et al.. (2023). International Society of Urological Pathology ( ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trial. British Journal of Urology. 133(2). 179–187. 2 indexed citations

Philipps, L., Núria Porta, Nicholas D. James, et al.. (2023). Differences in Quality of Life and Toxicity for Male and Female Patients following Chemo(radiotherapy) for Bladder Cancer. Clinical Oncology. 35(5). e336–e343. 2 indexed citations

Wilkins, Anna, Barry A. Gusterson, Holly Tovey, et al.. (2023). Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation. EBioMedicine. 88. 104436–104436. 5 indexed citations

Slevin, Finbar, Sarah Brown, Joanne Haviland, et al.. (2023). Hitting the Target: Developing High-quality Evidence for Proton Beam Therapy Through Randomised Controlled Trials. Clinical Oncology. 36(2). 70–79. 2 indexed citations

10.

Parker, Chris, Nina Tunariu, Holly Tovey, et al.. (2023). Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response. JNCI Cancer Spectrum. 7(6). 3 indexed citations

11.

Brown, Sarah, Samantha Hinsley, Emma Hall, et al.. (2022). A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations. Clinical Cancer Research. 28(17). 3639–3651. 4 indexed citations

12.

Wilkins, Anna, Olivia Naismith, Douglas Brand, et al.. (2020). Derivation of Dose/Volume Constraints for the Anorectum from Clinician- and Patient-Reported Outcomes in the CHHiP Trial of Radiation Therapy Fractionation. International Journal of Radiation Oncology*Biology*Physics. 106(5). 928–938. 31 indexed citations

13.

Hafeez, S., K. Warren-Oseni, Vibeke Hansen, et al.. (2020). Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance. BMJ Open. 10(5). e037134–e037134. 21 indexed citations

14.

Syndikus, Isabel, Clare Cruickshank, John Staffurth, et al.. (2020). PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018). Clinical and Translational Radiation Oncology. 25. 22–28. 31 indexed citations

15.

Naismith, Olivia, Clare Griffin, Isabel Syndikus, et al.. (2019). Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity. Clinical Oncology. 31(9). 600–610. 3 indexed citations

16.

Winfield, Jessica, David Dolling, Marcia Hall, et al.. (2019). Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker. Radiology. 293(2). 374–383. 24 indexed citations

17.

Wilkins, Anna, Shama Hassan, Claire Blanchard, et al.. (2018). Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer. Clinical and Translational Radiation Oncology. 10. 1–6. 1 indexed citations

18.

Alexander, Louise, et al.. (2014). The combination of non-selective NSAID 400 mg and paracetamol 1000 mg is more effective than each drug alone for treatment of acute pain. A systematic review.. PubMed. 38(1). 1–14. 7 indexed citations

19.

Nutting, Christopher M., James P. Morden, Kevin J. Harrington, et al.. (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. The Lancet Oncology. 12(2). 127–136. 1202 indexed citations breakdown →

20.

Bartlett, John M.S., Ian O. Ellis, Mitch Dowsett, et al.. (2007). Human Epidermal Growth Factor Receptor 2 Status Correlates With Lymph Node Involvement in Patients With Estrogen Receptor (ER) –Negative, but With Grade in Those With ER-Positive Early-Stage Breast Cancer Suitable for Cytotoxic Chemotherapy. Journal of Clinical Oncology. 25(28). 4423–4430. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact